ATTBF OTC
Abattis Bioceuticals Corp.
1W: -96.7%
1M: -96.7%
3M: -96.7%
YTD: -96.7%
1Y: -96.7%
3Y: -90.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
📊 Key Metrics
TTM$0M
Revenue
+4163.2% YoY
$-3M
Net Income
+96.1% YoY
$4M
Free Cash Flow
+151.1% YoY
71.7%
Gross Margin
-207.8%
Op. Margin
-400.9%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-27.0%
ROA-19.8%
ROIC-30.2%
Valuation
P/E-0.0
P/B0.0
EV/EBITDA0.0
Leverage
Debt/Equity0.14
Current Ratio0.73
Interest Cov.-61.0x
Quality Scores
Piotroski F4/9
Altman Z—
Beneish M92.22